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TRANSCRIPT: PRESENTATION ON DATA PRIVACY QUESTIONS IN THE DIGITAL
HEALTH WORLD
Presented By: Sara Gerke1

The Journal of Law and Health’s
Digital Health & Technology Symposium
CLEVELAND-MARSHALL COLLEGE OF LAW
FRIDAY, APRIL 8, 2022
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The following is a transcription from The Digital Health and Technology
Symposium presented at Cleveland-Marshall College of Law by The Journal of
Law & Health on Friday, April 8, 2022. This transcript has been lightly edited for
clarity.
Sara Gerke:
Thank you so much for having me. Today, I will discuss data privacy
questions in the digital health world. I thought I would first give you an overview
of the digital health landscape, and then we'll focus on the law – namely, the Health
Insurance, Portability, and Accountability Act (HIPAA), the EU General Data
Protection Regulation (GDPR), and the California Consumer Privacy Act of 2018
(CCPA).
Overview: Digital Health
Let’s start with an overview of what’s happening right now in the digital
health landscape. First, we need to define what digital health means. There are
different definitions of digital health, but the term is usually interpreted very
broadly. The Food and Drug Administration (FDA) counts the following categories
as digital health: mobile health (mHealth), health information technology (IT),
wearable devices, telehealth and telemedicine, and personalized medicine.2 I will
mainly focus on mHealth and wearable devices.
Digital health is really booming right now, especially due to the COVID-19
pandemic. It has led to the adoption of digital health tools. This slide shows the
estimated global digital health market size from 2019 to 2025. In 2022, the global
digital health market was worth about 334 billion U.S. dollars, and it is expected to
reach around $657 billion by 2025. This slide shows the projected U.S. mobile
health apps market size from 2020 to 2030. As you can see, the mHealth Apps
market is expected to increase continuously over the years. Medical apps make up
the majority of the market, but fitness apps play a significant role as well.
One example of a digital health app is Ada, a symptom checker. Once you
download the app, you answer a couple of questions about your symptoms. The app
will then suggest the condition and offer advice. You can also monitor changes in
your health. In addition, you can also receive heart health notifications on the Apple
watch. Apple not only offers an electrocardiogram app, but it also has an irregular
rhythm notification feature that notifies you if there's irregular heart rhythms,
suggestive of atrial fibrillation.
The size of the U.S. portable medical device market is also projected to
increase continuously over the next few years. In 2025, it is expected that the
2
What is Digital Health?, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/medicaldevices/digital-health-center-excellence/what-digital-health (last visited Sept. 8, 2022).
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biggest portion will be taken up by monitoring devices, which monitor vital signs
such as temperature and respiration rate. That will then be followed by smartphone
devices, which keep track of physical activities, followed by diagnostic imaging
and therapeutics.
In 2021, Google also announced its intention to start a pilot study of a
dermatology app that aims to help us better understand conditions affecting our
skin, nails, and hair. Users can take photos with their smartphones, ask questions,
and then get information about their possible conditions. However, this tool
received considerable criticism because of the limited training data set, which was
underinclusive of people with brown, dark brown, and black skin. This example of
bias proves we need to make sure that we train algorithms on a very diverse data
set.
Privacy Questions in Digital Health Landscape
Let’s discuss some of the privacy questions in the digital health landscape.
HIPAA is an abbreviation for the Health Insurance Portability and Accountability
Act. Its privacy rule aims to protect health privacy by regulating the use and
disclosure of certain health information.
The problem with HIPAA is that it does not adequately protect health
information in the digital health world. The scope of HIPAA includes only
protected health information generated by covered entities or their business
associates. So what does that mean? In general, protected health information means
individually identifiable health information. Covered entities are health plans such
as health insurance issuers, healthcare clearing houses such as billing services, and
most healthcare providers. A business associate is a person that performs certain
functions or activities, such as data analysis, on behalf of an entity or provides
services to a covered entity that involves the use or disclosure of protective health
information (PHI). This means that HIPAA does not apply to health information
generated by entities other than those covered by HIPAA.
For example, companies such as Amazon, Google, Microsoft, Facebook,
and Apple are usually not covered entities under HIPAA’s definition. This means
that the health information collected by wearable devices and health apps is usually
not protected under HIPAA. In some cases, companies like Apple and Google are
business associates under HIPAA, as is the case if the companies are collecting
protected health information through an app for a hospital. The business associate
agreement between the parties usually regulates the details of this data collection
and the data transfer.
Another shortcoming of HIPAA is the de-identification standard. Deidentification is usually accomplished by stripping out 18 types of identifiers, such
as the individual’s birthdate or their name. Once the data is de-identified, it can be
shared and used without violating HIPAA’s boundaries. However, in the digital
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health world, the privacy of individuals is not necessarily protected by the removal
of these 18 identifiers. Companies like Apple and Google have access to a lot of
data collected through their services, such as Google Maps. Carriers may be able to
re-identify the de-identified data with one of their other data sets of 10. This issue
is also known as data triangulation. The case of Dinerstein v. Google reflects the
issue that re-identification is often not difficult for technology giants like Google
to facilitate because they have other data sets on hand.3 In the case of Google, they
also had data from Google Maps.4 The case was dismissed because Stein was
unable to show damages, showing us quite plainly the challenges of successfully
suing hospitals for sharing patient data with companies like Google.5
In contrast to the U.S., the World Health Organization (WHO) has
implemented a much more comprehensive regulatory data protection framework.
Namely, the EU General Data Protection Regulation, known as the GDPR.6 The
GDPR has a much broader scope than HIPAA. Under Section 1, the GDPR applies
to the processing of personal data wholly or partly by automated means and to the
processing other than by automated means of personal data which form part of a
filing system or are intended to form part of a filing system. The GDPR defines the
term ‘personal data’ as ‘any information relating to an identified or identifiable
natural person, which is a so-called data subject.’ ‘Processing’ is defined as ‘any
operational set of operation, which is performed on personal data, or on sets of
personal data, whether or not by automated means, such as collection used for
storage.’ The GDPR also applies to data concerning health, which is defined under
Article 4 Section 15 as personal data related to the physical or mental health of a
natural person, including the provision of health care services, which reveal
information about his or her health status. In addition to its wide material scope, the
GDPR also has a very broad territorial scope. Under Article 3, the GDPR generally
applies to the processing of personal data in the context of the activities of an
establishment of a controller or a processor in the EU, regardless of whether the
processing takes place in the EU or not. In some cases, the GDPR even applies to
U.S. companies.
GDPR Provisions Addressing Personal Data
Under Article 3 Section 2, the GDPR applies to the processing of personal
data of data subjects who are in the EU by controller or processor not established
in the Union, where the processing activities are activities related to the offering of
goods or services (paid or for free). This processing is irrespective of whether
payment of the data subject is required for such data subjects in the EU, or the
3

Dinerstein v. Google, Ltd. Liab. Co., 484 F. Supp. 3d 561 (N.D. Ill. 2020).
Id. at 570.
5
Id. at 590-92.
6
Regulation (EU) 2016/679, of the European Parliament and of the Council of 27 April
2016 on the protection of natural persons with regard to the processing of personal data and on the
free movement of such data, and repealing Directive 95/46/EC (General Data Protection
Regulation),
2016
O.J.
(L
119)
1,
available
at
https://eurlex.europa.eu/legalcontent/EN/TXT/PDF/?uri=CELEC:32016R0679 [hereinafter GDPR].
4
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monitoring of their behavior as far as their behavior takes place within the EU. For
example, a U.S. company must comply with the GDPR in cases where the company
deliberately monitors the behavior of data subjects who are in the EU with the help
of health apps.
I would also like to highlight Article 9 of the GDPR. Article 9 Section 1 of
the GDPR bans the processing of special categories of personal data. Special
categories of personal data include data concerning health. However, Article 9
Section 4 of the GDPR contains some exception to this general ban, such as if there
is an explicit consent of the data subject for one or more specified purposes, or if
processing is necessary for reasons of public interest in the area of public health,
such as protecting against cross-border threats to health (which was a relevant
exception during the COVID-19 pandemic). The GDPR also contains many rights
of data subjects such as the right to be forgotten, in Article 17, and the right to data
portability, in Article 20.
In the U.S., we also see a trend at the state level to enact more
comprehensive privacy laws similar to the GDPR. For example, the California
Consumer Privacy Act (CCPA) of 2018 has been effective since January 2020.7
The CCPA grants various rights to California residents with regard to personal
information that is held by businesses. It is worth noting that the CCPA does not
apply to HIPAA-covered, protected health information; however, it applies to
personal health information that is collected outside of the traditional health setting,
such as through health apps. The California Privacy Rights Act of 2020 has also
recently been approved by California voters.8 It will become effective in January
2023 and will also further expand California consumer privacy rights to the
amendment of some of the CCPA’s provisions. Colorado has also recently passed
new comprehensive privacy laws,9 and several other states may enact new privacy
laws in the future.

7

California Consumer Privacy Act of 2018, CAL. CIV. CODE § 1798.100 (2018) (effective Jan. 1,
2020).
8
See The California Privacy Rights Act of 2020, WEIL, GOTSHAL & MANGES LLP,
https://www.weil.com/-/media/the-california-privacy-rights-act-of-2020-may-2021.pdf (last visited
Sept. 8, 2022).
9
Colorado Privacy Act, COLO. REV. STAT. § 6-1-1301 (2021).
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